Innoviva Inc (INVA):企業の財務・戦略的SWOT分析

◆英語タイトル:Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1682
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Innoviva Inc (INVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Innoviva Inc (Innoviva) partners with companies that advance innovative therapies for improving patient care and building long-lasting value. Its operations are focused on royalty management. The company partners with GSK for the commercialization and development of respiratory products.The company’s current portfolio includes respiratory assets partnered with Glaxo Group Limited (GSK) for various respiratory disorders. It receives royalty payments on the sale of these partnered products to clients as per the terms of its agreements with GSK. Innoviva is headquartered in Brisbane, California, the US

Innoviva Inc Key Recent Developments

Feb 05,2020 Innoviva reports fourth quarter 2019 financial results
Oct 30,2019 Innoviva reports third quarter 2019 financial results
Jul 24,2019 Innoviva reports second quarter 2019 financial results
May 01,2019 Innoviva reports first quarter 2019 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Innoviva Inc – Key Facts
Innoviva Inc – Key Employees
Innoviva Inc – Key Employee Biographies
Innoviva Inc – Major Products and Services
Innoviva Inc – History
Innoviva Inc – Company Statement
Innoviva Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Innoviva Inc – Business Description
R&D Overview
Innoviva Inc – Corporate Strategy
Innoviva Inc – SWOT Analysis
SWOT Analysis – Overview
Innoviva Inc – Strengths
Innoviva Inc – Weaknesses
Innoviva Inc – Opportunities
Innoviva Inc – Threats
Innoviva Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Innoviva Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 05, 2020: Innoviva reports fourth quarter 2019 financial results
Oct 30, 2019: Innoviva reports third quarter 2019 financial results
Jul 24, 2019: Innoviva reports second quarter 2019 financial results
May 01, 2019: Innoviva reports first quarter 2019 financial results
Feb 06, 2019: Innoviva reports fourth quarter 2018 financial results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Innoviva Inc, Key Facts
Innoviva Inc, Key Employees
Innoviva Inc, Key Employee Biographies
Innoviva Inc, Major Products and Services
Innoviva Inc, History
Innoviva Inc, Subsidiaries
Innoviva Inc, Key Competitors
Innoviva Inc, Ratios based on current share price
Innoviva Inc, Annual Ratios
Innoviva Inc, Annual Ratios (Cont...1)
Innoviva Inc, Annual Ratios (Cont...2)
Innoviva Inc, Interim Ratios
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Innoviva Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Innoviva Inc, Performance Chart (2015 - 2019)
Innoviva Inc, Ratio Charts
Innoviva Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Innoviva Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Innoviva Inc (INVA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ImaBiotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary ImaBiotech SAS (ImaBiotech) is a contract research organization that provides mass spectrometry imaging services. The organization offers software products such as multimaging and quantinetix. Its service portfolio includes consulting and training, biomarker discovery, pharmaco-kinetics and …
  • Ohio State University Comprehensive Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Ohio State University Comprehensive Cancer Center (OSUCCC), a subsidiary of Ohio State University is a healthcare institution that provides medical and academic education services. The institute provides education, research, and patient care services. Its service portfolio includes cancer di …
  • Polenergia SA (PEP):電力:M&Aディール及び事業提携情報
    Summary Polenergia SA (Polenergia) formerly Polish Energy Partners SA develops, implements and operates projects related to production of electricity and fuels. It offers services such as project implementation and supervision of construction, management of power facilities, production and sales of …
  • Ryosan Company, Ltd:企業の戦略・SWOT・財務情報
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ping An Insurance (Group) Company of China Ltd (601318):企業の財務・戦略的SWOT分析
    Ping An Insurance (Group) Company of China Ltd (601318) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • ING Bank NV:企業のM&A・事業提携・投資動向
    ING Bank NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ING Bank NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Visteon Corporation:企業の戦略・SWOT・財務情報
    Visteon Corporation - Strategy, SWOT and Corporate Finance Report Summary Visteon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Valeo S.A.:企業の戦略・SWOT・財務情報
    Valeo S.A. - Strategy, SWOT and Corporate Finance Report Summary Valeo S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Enthera Srl:製薬・医療:M&Aディール及び事業提携情報
    Summary Enthera Srl (Enthera), a subsidiary of BiovelocITA Srl, is a biotechnology company, which strives to discover novel medicines for the treatment of diabetes and related gastrointestinal disorders. Gastrointestinal symptoms such as diarrhea and abdominal pain among diabetics are referred to as …
  • Kirin Holdings Co Ltd:企業のM&A・事業提携・投資動向
    Kirin Holdings Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kirin Holdings Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • S Chand And Company Limited (SCHAND):企業の財務・戦略的SWOT分析
    S Chand And Company Limited (SCHAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • 7C Solarparken AG (HRPK):企業の財務・戦略的SWOT分析
    Summary 7C Solarparken AG (7C Solarparken), formerly Colexon Energy AG is a renewable energy company that develops and operates photovoltaic farms. The company operates, maintains, and administrates the photovoltaic power plants with acquisition, financing and optimization of operating assets. Its d …
  • Baylor Scott & White Health-製薬・医療分野:企業M&A・提携分析
    Summary Baylor Scott & White Health (Baylor Scott & White) is a non-profit organization that provides medical care services. The organization provides medical education, medical services and conducts medical research. It offers medical services in the area of emergency care, cancer care, behavioral …
  • ASC Pty Ltd:企業の戦略・SWOT・財務情報
    ASC Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary ASC Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Santen Inc-製薬・医療分野:企業M&A・提携分析
    Summary Santen Inc (Santen), a subsidiary of Santen Pharmaceutical Co Ltd is a developer, manufacturer and distributor of ophthalmic pharmaceutical products. The company offers products in therapeutic areas such as retinal disorders, glaucoma and corneal diseases. It conducts diagnosis on uveitis co …
  • The Aerospace Corporation:企業の戦略的SWOT分析
    The Aerospace Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Eregli Demir ve Celik Fabrikalari TAS:企業の戦略・SWOT・財務情報
    Eregli Demir ve Celik Fabrikalari TAS - Strategy, SWOT and Corporate Finance Report Summary Eregli Demir ve Celik Fabrikalari TAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Didi Chuxing Co Ltd:企業の戦略的SWOT分析
    Didi Chuxing Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Shinkin Central Bank:企業の戦略・SWOT・財務情報
    Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report Summary Shinkin Central Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tetra Technologies, Inc.:企業の戦略・SWOT・財務分析
    Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tetra Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆